Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
BMC Res Notes ; 10(1): 192, 2017 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-28583187

RESUMEN

BACKGROUND: Shigella is an important cause of bacterial gastroenteritis in resource-poor countries. The treatment of shigellosis mostly requires antibiotics. However, the increase of multidrug resistance along with emergence of extended-spectrum ß-lactamase and ciprofloxacin resistance among Shigella spp. has challenged the situation. This study was conducted to determine the distribution of species and antibiotic susceptibility pattern of Shigella species isolated from stool specimen among children less than 5 years of age in Nepal. RESULTS: Out of total 717 stool samples collected, 15 cases of Shigella spp. was isolated which includes 12 S. flexneri and 3 S. sonnei. Multidrug resistance was found among 13(86%) of the isolates. One of the isolates of S. flexneri was found to be ESBL-producer with MIC >256 mg/L for cefixime. CONCLUSION: The high occurrence of multidrug resistance among Shigella spp. along with a case of ESBL-production for the first time in Nepal alarms the concerns about dissemination of the resistant isolates. So, systemic monitoring of the antimicrobial susceptibility pattern of Shigella spp. is becoming crucial to guide therapy.


Asunto(s)
Antiinfecciosos/uso terapéutico , Disentería Bacilar/tratamiento farmacológico , Shigella/efectos de los fármacos , Centros de Atención Terciaria , Cefixima/uso terapéutico , Niño , Preescolar , Ciprofloxacina/uso terapéutico , Resistencia a Múltiples Medicamentos , Disentería Bacilar/microbiología , Heces/microbiología , Humanos , Lactante , Pruebas de Sensibilidad Microbiana , Nepal , Shigella/enzimología , Shigella/fisiología , beta-Lactamasas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA